Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan
· Delayed Price · Currency is TWD 133.00
+2.00 (1.53%)
Apr 2, 2025, 1:30 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 8.88 billion as of April 2, 2025. Its market cap has decreased by -67.80% in one year.
Market Cap
8.88B
Enterprise Value
6.45B
Revenue
5.82M
Ranking
n/a
PE Ratio
488.96
Stock Price
133.00
Market Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 8.88B, an increase of 246.37%. That is a compound annual growth rate of 31.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2025 | 8.88B | -6.01% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | 2.79B | 8.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 178.51B |
| Caliway Biopharmaceuticals | 113.99B |
| Bora Pharmaceuticals Co., LTD. | 71.78B |
| Lotus Pharmaceutical | 61.56B |
| Oneness Biotech | 32.98B |
| Lumosa Therapeutics | 29.22B |
| Pegavision | 28.08B |
| Polaris Group | 27.65B |